Replies to post #135 on Bluebird Bio Inc (BLUE)

[Frankestin]

fair value 40/45$!
1,3b cash

Why does is not so positive for BMY?

Because the approval took place in the US which is blue's market
and
As part of the Celgene-Bristol Myers deal, Celgene shareholders would have received a $ 9 per share payment if three of Celgene's top pipeline assets were approved by certain dates.